版本:
中国

BRIEF-Biopharmx says achieved primary endpoint in trial of treatment for acne

May 3 Biopharmx Corp

* Biopharmx Corp says achieved primary endpoint in its phase 2b clinical trial evaluating bpx-01

* Biopharmx Corp says based on these phase 2b results, Biopharmx continues to progress bpx-01 towards a phase 3 program Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐